L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

Integrative Biology

Volumn 3, Issue 4, 2011, Pages 479-489

  Gao, Feng ^a   Vasquez, Sergio X ^b   Su, Feng ^a   Roberts, Svetlana ^a   Shah, Neha ^b   Grijalva, Victor ^a   Imaizumi, Satoshi ^a   Chattopadhyay, Arnab ^a   Ganapathy, Ekambaram ^a   Meriwether, David ^a   Johnston, Brad ^b   Anantharamaiah, G M ^c   Navab, Mohamad ^a   Fogelman, Alan M ^a   Reddy, Srinivasa T ^a,d   Farias Eisner, Robin ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Numira Biosciences   (United States)

^c University of Alabama at Birmingham   (United States)

^d MRL 3736 ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; APOLIPOPROTEIN A1; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; L 4F; L 5F; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DOWNSTREAM PROCESSING; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR VOLUME;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; APOLIPOPROTEIN A-I; BLOOD VESSELS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MUS;

EID: 79953762012     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c0ib00147c     Document Type: Article

References (36)

1. K. R. Kozak, M. W. Amneus, S. M. Pusey, F. Su, M. N. Luong, S. A. Luong, S. T. Reddy and R. Farias-Eisner, Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 12343-12348.
2. K. R. Kozak, F. Su, J. P. Whitelegge, K. Faull, S. Reddy and R. Farias-Eisner, Proteomics, 2005, 5, 4589-4596.
3. V. Nosov, F. Su, M. Amneus, M. Birrer, T. Robins, J. Kotlerman, S. Reddy and R. Farias-Eisner, Am. J. Obstet. Gynecol., 2009, 200, 639.e1-e5.
4. F. Su, K. R. Kozak, S. Imaizumi, F. Gao, M. W. Amneus, V. Grijalva, C. Ng, A. Wagner, G. Houg, G. Farias-Eisner, G. M. Anantharamaiah, B. J. Van Lenten, M. Navab, A. M. Fogelman, S. T. Reddy and R. Farias-Eisner, Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 19997-20002.
5. M. Navab, G. M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, N. Yu, B. J. Ansell, G. Datta, D. W. Garber and A. M. Fogelman, Arterioscler. Thromb. Vasc. Biol., 2005, 25, 1325-1331.
6. M. Navab, I. Shechter, G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten and A. M. Fogelman, Arterioscler. Thromb. Vasc. Biol., 2010, 30, 164-168.
7. R. K. Jain, Science, 2005, 307, 58-62.
8. R. C. Jr. Bast, B. Hennessy and G. B. Mills, Nat. Rev. Cancer, 2009, 9, 415-428.
9. T. A. Yap, C. P. Carden and S. B. Kaye, Nat. Rev. Cancer, 2009, 9, 167-181.
10. T. A. Olson, D. Mohanraj, L. F. Carson and S. Ramakrishnan, Cancer Res., 1994, 54, 276-280.
11. P. J. Paley, K. A. Staskus, K. Gebhard, D. Mohanraj, L. B. Twiggs, L. F. Carson and S. Ramakrishnan, Cancer, 1997, 80, 98-106.
12. D. P. Barton, A. Cai, K. Wendt, M. Young, A. Gamero and S. De Cesare, Clin. Cancer Res., 1997, 3, 1579-1586.
13. B. Davidson, I. Goldberg, W. H. Gotlieb, J. Kopolovic, G. Ben-Baruch, J. M. Nesland and R. Reich, Mol. Cell. Endocrinol., 2002, 187, 39-45.
14. A. Gadducci, P. Viacava, S. Cosio, D. Cecchetti, G. Fanelli, A. Fanucchi, G. Teti and A. R. Genazzani, Anticancer Res., 2003, 23, 3001-3008.
15. J. H. Ahn, J. S. Kim, H. K. Yu, H. J. Lee and Y. Yoon, J. Biol. Chem., 2004, 279, 21808-21814.
16. J. Redondo-Munoz, M. Jose Terol, J. A. Garcia-Marco and A. Garcia-Pardo, Blood, 2008, 111, 383-386.
17. A. K. Olsson, A. Dimberg, J. Kreuger and L. Claesson-Welsh, Nat. Rev. Mol. Cell Biol., 2006, 7, 359-371.
18. M. Mohammadi, I. Dikic, A. Sorokin, W. H. Burgess, M. Jaye and J. Schlessinger, Mol. Cell Biol., 1996, 16, 977-989.
19. E. J. Goetzl, H. Dolezalova, Y. Kong, Y. L. Hu, R. B. Jaffe, K. R. Kalli and C. A. Conover, Cancer Res., 1999, 59, 5370-5375.
20. Y. L. Hu, M. K. Tee, E. J. Goetzl, N. Auersperg, G. B. Mills, N. Ferrara and R. B. Jaffe, J. Natl. Cancer Inst., 2001, 93, 762-768.
21. B. J. Van Lenten, A. C. Wagner, C. L. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, A. D. Watson, S. Hama, M. Navab, G. M. Anantharamaiah and A. M. Fogelman, J. Lipid Res., 2008, 49, 2302-2311.
22. S. Imaizumi, V. Grijalva, M. Navab, B. J. Van Lenten, A. C. Wagner, G. M. Anantharamiah, A. M. Fogelman and S. T. Reddy, Drug Metab. Lett., 2010, 4, 139-148.
23. Y. Xu, Z. Shen, D. W. Wiper, M. Wu, R. E. Morton, P. Elson, A. W. Kennedy, J. Belinson, M. Markman and G. Casey, J. Am. Med. Assoc., 1998, 280, 719-723.
24. D. L. Baker, P. Morrison, B. Miller, C. A. Riely, B. Tolley, A. M. Westermann, J. M. Bonfrer, E. Bais, W. H. Moolenaar and G. Tigyi, J. Am. Med. Assoc., 2002, 287, 3081-3082.
25. Y. J. Xiao, B. Schwartz, M. Washington, A. Kennedy, K. Webster, J. Belinson and Y. Xu, Anal. Biochem., 2001, 290, 302-313.
26. M. M. Ptaszynska, M. L. Pendrak, R. W. Bandle, M. L. Stracke and D. D. Roberts, Mol. Cancer Res., 2008, 6, 352-363.
27. F. Okada, J. W. Rak, B. S. Croix, B. Lieubeau, M. Kaya, L. Roncari, S. Shirasawa, T. Sasazuki and R. S. Kerbel, Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 3609-3614.
28. J. R. Conejo-Garcia, F. Benencia, M. C. Courreges, E. Kang, A. Mohamed-Hadley, R. J. Buckanovich, D. O. Holtz, A. Jenkins, H. Na, L. Zhang, D. S. Wagner, D. Katsaros, R. Caroll and G. Coukos, Nat. Med., 2004, 10, 950-958.
29. R. Kerbel and J. Folkman, Nat. Rev. Cancer, 2002, 2, 727-739.
30. L. M. Ellis and D. J. Hicklin, Nat. Rev. Cancer, 2008, 8, 579-591.
31. L. M. Ellis and D. J. Hicklin, Clin. Cancer Res., 2008, 14, 6371-6375.
32. G. Bergers and D. Hanahan, Nat. Rev. Cancer, 2008, 8, 592-603.
33. R. Phillips, T. Ursell, P. Wiggins and P. Sens, Nature, 2009, 459, 379-85.
34. L. Yvan-Charvet, T. Pagler, E. L. Gautier, S. Avagyan, R. L. Siry, S. Han, C. L. Welch, N. Wang, G. J. Randolph, H. W. Snoeck and A. R. Tall, Science, 2010, 328, 1689-1693.
35. A. C. Lake, R. Vassy, M. Di benedetto, D. Lavigne, C. Le Visage, G. Y. Perret and D. Letourneur, J. Biol. Chem., 2006, 281, 37844-37852.
36. J. Gavard and J. S. Gutkind, Nat. Cell Biol., 2006, 8, 1223-1234.